https://stock.noler.com/us/stock/clovis-oncology-inc https://stock.noler.com/us/stock/clovis-oncology-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/clovis-oncology-inc/accounts-payable https://stock.noler.com/us/stock/clovis-oncology-inc/accounts-receivable https://stock.noler.com/us/stock/clovis-oncology-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/clovis-oncology-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/clovis-oncology-inc/accretion-expense https://stock.noler.com/us/stock/clovis-oncology-inc/accrual-at-carrying-value https://stock.noler.com/us/stock/clovis-oncology-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/clovis-oncology-inc/accrued-liabilities-current https://stock.noler.com/us/stock/clovis-oncology-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/clovis-oncology-inc/accrued-royalties-current https://stock.noler.com/us/stock/clovis-oncology-inc/accumulated-depreciation https://stock.noler.com/us/stock/clovis-oncology-inc/acquisition-consideration-transferred-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/clovis-oncology-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/clovis-oncology-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/clovis-oncology-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/acquisitions https://stock.noler.com/us/stock/clovis-oncology-inc/additional-paid-in-capital https://stock.noler.com/us/stock/clovis-oncology-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/clovis-oncology-inc/advertising-expense https://stock.noler.com/us/stock/clovis-oncology-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/clovis-oncology-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/clovis-oncology-inc/amortization https://stock.noler.com/us/stock/clovis-oncology-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/clovis-oncology-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/clovis-oncology-inc/aoci https://stock.noler.com/us/stock/clovis-oncology-inc/asset-impairment-charges https://stock.noler.com/us/stock/clovis-oncology-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/clovis-oncology-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-current https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-unrealized-loss-position-12-months-or-longer-aggregate-losses https://stock.noler.com/us/stock/clovis-oncology-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/clovis-oncology-inc/basic-shares https://stock.noler.com/us/stock/clovis-oncology-inc/capital-expenditures https://stock.noler.com/us/stock/clovis-oncology-inc/capital-lease-obligations https://stock.noler.com/us/stock/clovis-oncology-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/clovis-oncology-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/clovis-oncology-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/clovis-oncology-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/clovis-oncology-inc/cash-and-equivalents https://stock.noler.com/us/stock/clovis-oncology-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/clovis-oncology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/clovis-oncology-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/clovis-oncology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/clovis-oncology-inc/common-stock-value https://stock.noler.com/us/stock/clovis-oncology-inc/comprehensive-income https://stock.noler.com/us/stock/clovis-oncology-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/clovis-oncology-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/clovis-oncology-inc/convertible-debt-current https://stock.noler.com/us/stock/clovis-oncology-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/clovis-oncology-inc/cost-of-goods-sold https://stock.noler.com/us/stock/clovis-oncology-inc/cost-of-goods-sold-depreciation-depletion-and-amortization https://stock.noler.com/us/stock/clovis-oncology-inc/cost-of-revenue https://stock.noler.com/us/stock/clovis-oncology-inc/costs-and-expenses https://stock.noler.com/us/stock/clovis-oncology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/clovis-oncology-inc/current-assets https://stock.noler.com/us/stock/clovis-oncology-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/clovis-oncology-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/clovis-oncology-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/clovis-oncology-inc/current-liabilities https://stock.noler.com/us/stock/clovis-oncology-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/clovis-oncology-inc/damages-paid-value https://stock.noler.com/us/stock/clovis-oncology-inc/debt-carrying-amount https://stock.noler.com/us/stock/clovis-oncology-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/clovis-oncology-inc/debt-face-amount https://stock.noler.com/us/stock/clovis-oncology-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/clovis-oncology-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/clovis-oncology-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/clovis-oncology-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-finance-costs-gross https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-long-term-liability-charges https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-revenue https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-unrealized-currency-losses https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/clovis-oncology-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/clovis-oncology-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/clovis-oncology-inc/depreciation https://stock.noler.com/us/stock/clovis-oncology-inc/depreciation-and-amortization https://stock.noler.com/us/stock/clovis-oncology-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/clovis-oncology-inc/diluted-shares https://stock.noler.com/us/stock/clovis-oncology-inc/due-from-related-parties https://stock.noler.com/us/stock/clovis-oncology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/clovis-oncology-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/clovis-oncology-inc/effective-tax-rate https://stock.noler.com/us/stock/clovis-oncology-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/clovis-oncology-inc/eps https://stock.noler.com/us/stock/clovis-oncology-inc/eps-basic https://stock.noler.com/us/stock/clovis-oncology-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/clovis-oncology-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/clovis-oncology-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/clovis-oncology-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/clovis-oncology-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/clovis-oncology-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/clovis-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/clovis-oncology-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-current https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/clovis-oncology-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/clovis-oncology-inc/financing-cash-flow https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/clovis-oncology-inc/finite-lived-intangible-assets-translation-adjustments https://stock.noler.com/us/stock/clovis-oncology-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/clovis-oncology-inc/foreign-pretax-income https://stock.noler.com/us/stock/clovis-oncology-inc/form-d-other https://stock.noler.com/us/stock/clovis-oncology-inc/form-d-stocks https://stock.noler.com/us/stock/clovis-oncology-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/clovis-oncology-inc/gain-loss-on-repurchase-of-debt-instrument https://stock.noler.com/us/stock/clovis-oncology-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/clovis-oncology-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/clovis-oncology-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/clovis-oncology-inc/general-and-administrative-expense https://stock.noler.com/us/stock/clovis-oncology-inc/goodwill https://stock.noler.com/us/stock/clovis-oncology-inc/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/clovis-oncology-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/clovis-oncology-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/clovis-oncology-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/clovis-oncology-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/clovis-oncology-inc/income-tax https://stock.noler.com/us/stock/clovis-oncology-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/clovis-oncology-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/clovis-oncology-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/clovis-oncology-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/clovis-oncology-inc/insider-transactions-preferred https://stock.noler.com/us/stock/clovis-oncology-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/clovis-oncology-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/clovis-oncology-inc/insurance-settlements-receivable-current https://stock.noler.com/us/stock/clovis-oncology-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/clovis-oncology-inc/interest-expense https://stock.noler.com/us/stock/clovis-oncology-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/clovis-oncology-inc/interest-expense-lessee-assets-under-capital-lease https://stock.noler.com/us/stock/clovis-oncology-inc/interest-expense-on-debt https://stock.noler.com/us/stock/clovis-oncology-inc/interest-expense-other https://stock.noler.com/us/stock/clovis-oncology-inc/interest-paid https://stock.noler.com/us/stock/clovis-oncology-inc/interest-paid-net https://stock.noler.com/us/stock/clovis-oncology-inc/interest-payable-current https://stock.noler.com/us/stock/clovis-oncology-inc/interest-receivable-current https://stock.noler.com/us/stock/clovis-oncology-inc/inventory https://stock.noler.com/us/stock/clovis-oncology-inc/inventory-adjustments https://stock.noler.com/us/stock/clovis-oncology-inc/inventory-finished-goods https://stock.noler.com/us/stock/clovis-oncology-inc/inventory-gross https://stock.noler.com/us/stock/clovis-oncology-inc/inventory-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/inventory-work-in-process https://stock.noler.com/us/stock/clovis-oncology-inc/investing-cash-flow https://stock.noler.com/us/stock/clovis-oncology-inc/lease-and-rental-expense https://stock.noler.com/us/stock/clovis-oncology-inc/lease-cost https://stock.noler.com/us/stock/clovis-oncology-inc/lease-incentive-receivable-current https://stock.noler.com/us/stock/clovis-oncology-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/clovis-oncology-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/clovis-oncology-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/clovis-oncology-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/clovis-oncology-inc/level-3-liability-change https://stock.noler.com/us/stock/clovis-oncology-inc/liabilities-fair-value-adjustment https://stock.noler.com/us/stock/clovis-oncology-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/clovis-oncology-inc/liabilities-fair-value-disclosure-recurring https://stock.noler.com/us/stock/clovis-oncology-inc/liabilities-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/liabilities-other-than-longterm-debt-noncurrent https://stock.noler.com/us/stock/clovis-oncology-inc/litigation-reserve-current https://stock.noler.com/us/stock/clovis-oncology-inc/litigation-settlement-expense https://stock.noler.com/us/stock/clovis-oncology-inc/long-term-debt https://stock.noler.com/us/stock/clovis-oncology-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/clovis-oncology-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/clovis-oncology-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/clovis-oncology-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/clovis-oncology-inc/net-change-in-cash https://stock.noler.com/us/stock/clovis-oncology-inc/net-income https://stock.noler.com/us/stock/clovis-oncology-inc/number-of-operating-segments https://stock.noler.com/us/stock/clovis-oncology-inc/number-of-reportable-segments https://stock.noler.com/us/stock/clovis-oncology-inc/oci-before-tax https://stock.noler.com/us/stock/clovis-oncology-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/clovis-oncology-inc/oci-net-of-tax https://stock.noler.com/us/stock/clovis-oncology-inc/oci-tax https://stock.noler.com/us/stock/clovis-oncology-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/clovis-oncology-inc/operating-cash-flow https://stock.noler.com/us/stock/clovis-oncology-inc/operating-expenses https://stock.noler.com/us/stock/clovis-oncology-inc/operating-income https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-cost https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-liability https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/clovis-oncology-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/clovis-oncology-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/clovis-oncology-inc/other-assets-miscellaneous https://stock.noler.com/us/stock/clovis-oncology-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/clovis-oncology-inc/other-current-assets https://stock.noler.com/us/stock/clovis-oncology-inc/other-income https://stock.noler.com/us/stock/clovis-oncology-inc/other-noncurrent-assets https://stock.noler.com/us/stock/clovis-oncology-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/clovis-oncology-inc/other-nonoperating-expense https://stock.noler.com/us/stock/clovis-oncology-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/clovis-oncology-inc/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/clovis-oncology-inc/other-receivables https://stock.noler.com/us/stock/clovis-oncology-inc/other-than-temporary-impairment-loss-debt-securities-available-for-sale https://stock.noler.com/us/stock/clovis-oncology-inc/paid-in-capital-other https://stock.noler.com/us/stock/clovis-oncology-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/clovis-oncology-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/clovis-oncology-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/clovis-oncology-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/clovis-oncology-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/clovis-oncology-inc/payments-to-suppliers https://stock.noler.com/us/stock/clovis-oncology-inc/preferred-shares-facts https://stock.noler.com/us/stock/clovis-oncology-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/clovis-oncology-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/clovis-oncology-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/clovis-oncology-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/clovis-oncology-inc/prepaid-advertising https://stock.noler.com/us/stock/clovis-oncology-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/clovis-oncology-inc/prepaid-expense-current https://stock.noler.com/us/stock/clovis-oncology-inc/prepaid-insurance https://stock.noler.com/us/stock/clovis-oncology-inc/pretax-income https://stock.noler.com/us/stock/clovis-oncology-inc/pretax-income-domestic https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-issuance-of-senior-long-term-debt https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/clovis-oncology-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/clovis-oncology-inc/profit-loss https://stock.noler.com/us/stock/clovis-oncology-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/clovis-oncology-inc/property-plant-equipment https://stock.noler.com/us/stock/clovis-oncology-inc/public-float https://stock.noler.com/us/stock/clovis-oncology-inc/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/clovis-oncology-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/clovis-oncology-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/clovis-oncology-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/clovis-oncology-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/clovis-oncology-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/clovis-oncology-inc/research-and-development-in-process https://stock.noler.com/us/stock/clovis-oncology-inc/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/clovis-oncology-inc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/clovis-oncology-inc/retained-earnings https://stock.noler.com/us/stock/clovis-oncology-inc/revenue https://stock.noler.com/us/stock/clovis-oncology-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/clovis-oncology-inc/revenue-from-grants https://stock.noler.com/us/stock/clovis-oncology-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/clovis-oncology-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/clovis-oncology-inc/severance-costs https://stock.noler.com/us/stock/clovis-oncology-inc/sga-expense https://stock.noler.com/us/stock/clovis-oncology-inc/share-price https://stock.noler.com/us/stock/clovis-oncology-inc/shareholders-equity https://stock.noler.com/us/stock/clovis-oncology-inc/shares-authorized https://stock.noler.com/us/stock/clovis-oncology-inc/shares-issued https://stock.noler.com/us/stock/clovis-oncology-inc/shares-issued-2 https://stock.noler.com/us/stock/clovis-oncology-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/clovis-oncology-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/clovis-oncology-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/clovis-oncology-inc/short-term-lease-cost https://stock.noler.com/us/stock/clovis-oncology-inc/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/clovis-oncology-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/clovis-oncology-inc/stock-based-compensation https://stock.noler.com/us/stock/clovis-oncology-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/clovis-oncology-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/clovis-oncology-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/clovis-oncology-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/clovis-oncology-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/clovis-oncology-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/clovis-oncology-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/clovis-oncology-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/clovis-oncology-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/clovis-oncology-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/clovis-oncology-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/clovis-oncology-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/clovis-oncology-inc/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/clovis-oncology-inc/taxes-payable-current https://stock.noler.com/us/stock/clovis-oncology-inc/total-assets https://stock.noler.com/us/stock/clovis-oncology-inc/total-liabilities https://stock.noler.com/us/stock/clovis-oncology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/clovis-oncology-inc/total-long-term-debt https://stock.noler.com/us/stock/clovis-oncology-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/clovis-oncology-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/clovis-oncology-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/clovis-oncology-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/clovis-oncology-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/clovis-oncology-inc/utb-increase-from-settlements https://stock.noler.com/us/stock/clovis-oncology-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/clovis-oncology-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/clovis-oncology-inc/value-added-tax-receivable-current https://stock.noler.com/us/stock/clovis-oncology-inc/variable-lease-cost https://stock.noler.com/us/stock/clovis-oncology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/clovis-oncology-inc/write-off-of-deferred-debt-issuance-cost